Answer
Yes. Shortness of breath is a recognised common adverse effect, but severe or sudden symptoms require immediate assessment.
Sources for this answer
- Kengrexal 50 mg powder for concentrate for solution for injection / infusion. — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.